Literature DB >> 2850289

Interpretative criteria for the agar diffusion susceptibility test with azithromycin.

A L Barry1, R N Jones.   

Abstract

Azithromycin (CP-62,993) is a macrolide with a tendency to concentrate in various body tissues. Difficulties that arise when establishing tentative minimum inhibitory concentration (MIC) breakpoints for such a drug include the question of whether MICs should be compared with the achievable concentrations in blood or in tissue. Pending clinical experience with this drug, we recommend the following tentative criteria for interpreting tests with 15 micrograms azithromycin discs: susceptible greater than or equal to 18 mm (MIC less than or equal to 2 mg/l) and resistant less than or equal to 13 mm (MIC greater than or equal to 8 mg/l).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850289     DOI: 10.1093/jac/22.5.637

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Safety, toleration, and pharmacokinetics of intravenous azithromycin.

Authors:  D R Luke; G Foulds; S F Cohen; B Levy
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

2.  Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.

Authors:  A L Barry; C Thornsberry; T L Gavan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

3.  Influence of the test medium on azithromycin and erythromycin regression statistics.

Authors:  A L Barry; P C Fuchs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-10       Impact factor: 3.267

Review 4.  Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.

Authors:  D H Peters; H A Friedel; D McTavish
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

5.  In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans.

Authors:  R Pajukanta; S Asikainen; M Saarela; S Alaluusua; H Jousimies-Somer
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

6.  Helicobacter pylori infection in a pediatric population: in vitro susceptibilities to omeprazole and eight antimicrobial agents.

Authors:  V G Loo; P Sherman; A G Matlow
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.